Zimmer Holdings (NYSE:ZMH) had its price target upped by Piper Jaffray Cos. from $100.00 to $114.00 in a research note issued to investors on Friday, American Banking & Market News reports.
ZMH has been the subject of a number of other recent research reports. Analysts at Needham & Company raised their price target on shares of Zimmer Holdings from $98.00 to $106.00 in a research note to investors on Friday. They now have a buy rating on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of Zimmer Holdings from $87.00 to $92.00 in a research note to investors on Friday. They now have a hold rating on the stock. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Zimmer Holdings from $78.00 to $88.00 in a research note to investors on Friday. They now have a buy rating on the stock. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and ten have assigned a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of $87.82.
Zimmer Holdings (NYSE:ZMH) traded down 0.20% on Friday, hitting $87.95. 396,700 shares of the company’s stock traded hands. Zimmer Holdings has a 52-week low of $61.58 and a 52-week high of $85.08. The stock’s 50-day moving average is $81.18 and its 200-day moving average is $77.98. The company has a market cap of $14.951 billion and a price-to-earnings ratio of 22.34.
Zimmer Holdings (NYSE:ZMH) last announced its earnings results on Thursday, October 24th. The company reported $1.25 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.24 by $0.01. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the prior year, the company posted $1.15 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. On average, analysts predict that Zimmer Holdings will post $5.71 earnings per share for the current fiscal year.
Zimmer Holdings, Inc (NYSE:ZMH) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.